25 XP   0   0   10

Renalytix AI plc
Buy, Hold or Sell?

Let's analyse Renalytix together

PenkeI guess you are interested in Renalytix AI plc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Renalytix AI plc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Renalytix AI plc

I send you an email if I find something interesting about Renalytix AI plc.

Quick analysis of Renalytix (30 sec.)










What can you expect buying and holding a share of Renalytix? (30 sec.)

How much money do you get?

How much money do you get?
p0.47
When do you have the money?
1 year
How often do you get paid?
4.5%

What is your share worth?

Current worth
p2.11
Expected worth in 1 year
p-2.81
How sure are you?
36.4%

+ What do you gain per year?

Total Gains per Share
p32.57
Return On Investment
93.1%

For what price can you sell your share?

Current Price per Share
p35.00
Expected price per share
p20.88 - p53.00
How sure are you?
50%

1. Valuation of Renalytix (5 min.)




Live pricePrice per Share (EOD)

p35.00

Intrinsic Value Per Share

p-183.74 - p-208.45

Total Value Per Share

p-181.63 - p-206.34

2. Growth of Renalytix (5 min.)




Is Renalytix growing?

Current yearPrevious yearGrowGrow %
How rich?$2.6m$25m-$18.5m-282.3%

How much money is Renalytix making?

Current yearPrevious yearGrowGrow %
Making money-$10.6m-$12.4m$1.8m17.5%
Net Profit Margin-1,829.0%-1,364.9%--

How much money comes from the company's main activities?

3. Financial Health of Renalytix (5 min.)




4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  


Richest
#91 / 122

Most Revenue
#105 / 122

Most Profit
#100 / 122

Most Efficient
#120 / 122

What can you expect buying and holding a share of Renalytix? (5 min.)

Welcome investor! Renalytix's management wants to use your money to grow the business. In return you get a share of Renalytix.

What can you expect buying and holding a share of Renalytix?

First you should know what it really means to hold a share of Renalytix. And how you can make/lose money.

Speculation

The Price per Share of Renalytix is p35.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Renalytix.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Renalytix, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is p2.11. Based on the TTM, the Book Value Change Per Share is p-1.23 per quarter. Based on the YOY, the Book Value Change Per Share is p-12.43 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is p9.38 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Renalytix.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 p% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Share
Usd Eps-0.09-0.3%-0.08-0.2%-0.11-0.3%-0.09-0.3%-0.08-0.2%
Usd Book Value Change Per Share0.040.1%-0.020.0%-0.16-0.4%-0.010.0%0.000.0%
Usd Dividend Per Share0.000.0%0.120.3%0.000.0%0.020.1%0.020.1%
Usd Total Gains Per Share0.040.1%0.100.3%-0.16-0.4%0.010.0%0.020.1%
Usd Price Per Share0.20-0.86-1.60-4.33-4.01-
Price to Earnings Ratio-0.54--21.49--3.98--25.74--24.80-
Price-to-Total Gains Ratio4.70--5.52--2.67--193.73--193.73-
Price to Book Ratio7.33-119.85-7.23-32.28-29.58-
Price-to-Total Gains Ratio4.70--5.52--2.67--193.73--193.73-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.44163
Number of shares2264
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.120.02
Usd Book Value Change Per Share-0.02-0.01
Usd Total Gains Per Share0.100.01
Gains per Quarter (2264 shares)232.6322.03
Gains per Year (2264 shares)930.5288.11
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11071-141921214-12678
22143-2811852429-252166
33214-4222783643-378254
44285-5633714857-505342
55356-70446451071-631430
66428-84455761286-757518
77499-98565071500-883606
88570-112674381714-1009694
99641-126783691928-1135782
1010713-140793002143-1261870

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.022.00.00.0%0.022.00.00.0%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%6.011.03.030.0%7.011.04.031.8%7.011.04.031.8%
Dividend per Share1.00.03.025.0%1.00.011.08.3%1.00.019.05.0%1.00.021.04.5%1.00.021.04.5%
Total Gains per Share3.01.00.075.0%5.07.00.041.7%7.010.03.035.0%8.010.04.036.4%8.010.04.036.4%

Fundamentals of Renalytix

About Renalytix AI plc

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix Plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; and Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is based in New York, New York.

Fundamental data was last updated by Penke on 2024-03-12 15:46:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is unable to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Renalytix AI plc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Renalytix earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Renalytix to the Health Information Services industry mean.
  • A Net Profit Margin of -1,288.0% means that -12.88 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Renalytix AI plc:

  • The MRQ is -1,288.0%. The company is making a huge loss. -2
  • The TTM is -1,829.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,288.0%TTM-1,829.0%+541.0%
TTM-1,829.0%YOY-1,364.9%-464.0%
TTM-1,829.0%5Y-1,215.4%-613.6%
5Y-1,215.4%10Y-1,104.9%-110.5%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,288.0%-18.8%-1,269.2%
TTM-1,829.0%-21.3%-1,807.7%
YOY-1,364.9%-28.1%-1,336.8%
5Y-1,215.4%-32.6%-1,182.8%
10Y-1,104.9%-41.1%-1,063.8%
1.1.2. Return on Assets

Shows how efficient Renalytix is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Renalytix to the Health Information Services industry mean.
  • -41.7% Return on Assets means that Renalytix generated -0.42 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Renalytix AI plc:

  • The MRQ is -41.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -40.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-41.7%TTM-40.1%-1.7%
TTM-40.1%YOY-29.4%-10.7%
TTM-40.1%5Y-18.8%-21.3%
5Y-18.8%10Y-17.5%-1.3%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-41.7%-4.3%-37.4%
TTM-40.1%-5.8%-34.3%
YOY-29.4%-5.2%-24.2%
5Y-18.8%-5.8%-13.0%
10Y-17.5%-8.0%-9.5%
1.1.3. Return on Equity

Shows how efficient Renalytix is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Renalytix to the Health Information Services industry mean.
  • -342.4% Return on Equity means Renalytix generated -3.42 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Renalytix AI plc:

  • The MRQ is -342.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -142.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-342.4%TTM-142.2%-200.2%
TTM-142.2%YOY-64.9%-77.3%
TTM-142.2%5Y-46.7%-95.5%
5Y-46.7%10Y-42.8%-3.9%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-342.4%-4.0%-338.4%
TTM-142.2%-5.9%-136.3%
YOY-64.9%-7.9%-57.0%
5Y-46.7%-7.6%-39.1%
10Y-42.8%-9.6%-33.2%

1.2. Operating Efficiency of Renalytix AI plc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Renalytix is operating .

  • Measures how much profit Renalytix makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Renalytix to the Health Information Services industry mean.
  • An Operating Margin of 0.0% means the company generated 0.00  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Renalytix AI plc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1,150.5%+1,150.5%
TTM-1,150.5%YOY-1,276.0%+125.5%
TTM-1,150.5%5Y-1,043.3%-107.2%
5Y-1,043.3%10Y-948.4%-94.8%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ--17.8%+17.8%
TTM-1,150.5%-11.4%-1,139.1%
YOY-1,276.0%-24.9%-1,251.1%
5Y-1,043.3%-18.8%-1,024.5%
10Y-948.4%-28.4%-920.0%
1.2.2. Operating Ratio

Measures how efficient Renalytix is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 14.31 means that the operating costs are 14.31 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Renalytix AI plc:

  • The MRQ is 14.312. The company is inefficient in keeping operating costs low. -1
  • The TTM is 17.734. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ14.312TTM17.734-3.422
TTM17.734YOY14.458+3.276
TTM17.7345Y12.858+4.876
5Y12.85810Y11.689+1.169
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ14.3121.266+13.046
TTM17.7341.376+16.358
YOY14.4581.407+13.051
5Y12.8581.327+11.531
10Y11.6891.332+10.357

1.3. Liquidity of Renalytix AI plc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Renalytix is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 0.68 means the company has 0.68 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Renalytix AI plc:

  • The MRQ is 0.681. The company is unable to pay all its short-term debts. -2
  • The TTM is 1.466. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ0.681TTM1.466-0.785
TTM1.466YOY2.702-1.236
TTM1.4665Y8.746-7.279
5Y8.74610Y9.441-0.695
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6811.660-0.979
TTM1.4661.735-0.269
YOY2.7022.035+0.667
5Y8.7462.603+6.143
10Y9.4412.525+6.916
1.3.2. Quick Ratio

Measures if Renalytix is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Renalytix to the Health Information Services industry mean.
  • A Quick Ratio of 0.19 means the company can pay off 0.19 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Renalytix AI plc:

  • The MRQ is 0.186. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is -82.274. The company is unable to pay all its short-term debts with the most liquid assets. -2
Trends
Current periodCompared to+/- 
MRQ0.186TTM-82.274+82.461
TTM-82.274YOY2.634-84.908
TTM-82.2745Y-11.722-70.552
5Y-11.72210Y-10.650-1.072
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1861.121-0.935
TTM-82.2741.186-83.460
YOY2.6341.695+0.939
5Y-11.7221.953-13.675
10Y-10.6501.898-12.548

1.4. Solvency of Renalytix AI plc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Renalytix assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Renalytix to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.88 means that Renalytix assets are financed with 87.8% credit (debt) and the remaining percentage (100% - 87.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Renalytix AI plc:

  • The MRQ is 0.878. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.818. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.878TTM0.818+0.060
TTM0.818YOY0.470+0.348
TTM0.8185Y0.295+0.524
5Y0.29510Y0.270+0.024
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8780.428+0.450
TTM0.8180.430+0.388
YOY0.4700.397+0.073
5Y0.2950.414-0.119
10Y0.2700.446-0.176
1.4.2. Debt to Equity Ratio

Measures if Renalytix is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Renalytix to the Health Information Services industry mean.
  • A Debt to Equity ratio of 720.2% means that company has 7.20 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Renalytix AI plc:

  • The MRQ is 7.202. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.949. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ7.202TTM2.949+4.252
TTM2.949YOY1.121+1.829
TTM2.9495Y0.854+2.095
5Y0.85410Y0.779+0.075
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ7.2020.610+6.592
TTM2.9490.616+2.333
YOY1.1210.651+0.470
5Y0.8540.715+0.139
10Y0.7790.671+0.108

2. Market Valuation of Renalytix AI plc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Renalytix generates.

  • Above 15 is considered overpriced but always compare Renalytix to the Health Information Services industry mean.
  • A PE ratio of -0.54 means the investor is paying -0.54 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Renalytix AI plc:

  • The EOD is -1.209. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.536. Based on the earnings, the company is expensive. -2
  • The TTM is -21.495. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.209MRQ-0.536-0.674
MRQ-0.536TTM-21.495+20.959
TTM-21.495YOY-3.981-17.514
TTM-21.4955Y-25.743+4.248
5Y-25.74310Y-24.799-0.944
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-1.209-1.288+0.079
MRQ-0.536-1.437+0.901
TTM-21.495-1.650-19.845
YOY-3.981-3.185-0.796
5Y-25.743-6.094-19.649
10Y-24.799-5.971-18.828
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Renalytix AI plc:

  • The EOD is -1.408. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.624. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.054. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.408MRQ-0.624-0.784
MRQ-0.624TTM-2.054+1.431
TTM-2.054YOY-4.837+2.782
TTM-2.0545Y-10.564+8.510
5Y-10.56410Y-9.604-0.960
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-1.408-1.899+0.491
MRQ-0.624-2.501+1.877
TTM-2.054-3.132+1.078
YOY-4.837-5.389+0.552
5Y-10.564-6.141-4.423
10Y-9.604-6.517-3.087
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Renalytix is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of 7.33 means the investor is paying 7.33 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Renalytix AI plc:

  • The EOD is 16.563. Based on the equity, the company is expensive. -2
  • The MRQ is 7.335. Based on the equity, the company is overpriced. -1
  • The TTM is 119.848. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD16.563MRQ7.335+9.228
MRQ7.335TTM119.848-112.514
TTM119.848YOY7.226+112.622
TTM119.8485Y32.282+87.567
5Y32.28210Y29.577+2.705
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD16.5631.495+15.068
MRQ7.3351.692+5.643
TTM119.8481.838+118.010
YOY7.2262.891+4.335
5Y32.2824.349+27.933
10Y29.5774.177+25.400
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Renalytix AI plc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--3.295-1.232+137%-12.433+477%-1.104+134%0.096+3330%
Book Value Per Share--2.1133.872-45%19.871-89%31.409-93%30.753-93%
Current Ratio--0.6811.466-54%2.702-75%8.746-92%9.441-93%
Debt To Asset Ratio--0.8780.818+7%0.470+87%0.295+198%0.270+225%
Debt To Equity Ratio--7.2022.949+144%1.121+543%0.854+743%0.779+824%
Dividend Per Share---9.375-100%-0%1.875-100%1.705-100%
Eps---7.236-6.107-16%-8.418+16%-7.093-2%-6.539-10%
Free Cash Flow Per Share---6.214-7.838+26%-7.264+17%-6.856+10%-6.856+10%
Free Cash Flow To Equity Per Share---6.214-4.481-28%-2.535-59%-0.960-85%-0.960-85%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---208.451--------
Intrinsic Value_10Y_min---183.740--------
Intrinsic Value_1Y_max---28.224--------
Intrinsic Value_1Y_min---27.727--------
Intrinsic Value_3Y_max---79.210--------
Intrinsic Value_3Y_min---75.734--------
Intrinsic Value_5Y_max---123.458--------
Intrinsic Value_5Y_min---115.071--------
Market Cap3497557000.000+56%1548918100.00075369690550.000-98%12653661575.000-88%48008433775.000-97%44200460227.273-96%
Net Profit Margin---12.880-18.290+42%-13.649+6%-12.154-6%-11.049-14%
Operating Margin----11.5050%-12.7600%-10.4330%-9.4840%
Operating Ratio--14.31217.734-19%14.458-1%12.858+11%11.689+22%
Pb Ratio16.563+56%7.335119.848-94%7.226+2%32.282-77%29.577-75%
Pe Ratio-1.209-126%-0.536-21.495+3914%-3.981+643%-25.743+4707%-24.799+4531%
Price Per Share35.000+56%15.50068.375-77%126.625-88%343.250-95%317.614-95%
Price To Free Cash Flow Ratio-1.408-126%-0.624-2.054+229%-4.837+676%-10.564+1594%-9.604+1440%
Price To Total Gains Ratio10.623+56%4.705-5.522+217%-2.671+157%-193.731+4218%-193.731+4218%
Quick Ratio--0.186-82.274+44245%2.634-93%-11.722+6390%-10.650+5814%
Return On Assets---0.417-0.401-4%-0.294-30%-0.188-55%-0.175-58%
Return On Equity---3.424-1.422-58%-0.649-81%-0.467-86%-0.428-87%
Total Gains Per Share--3.2958.143-60%-12.433+477%0.771+327%1.801+83%
Usd Book Value--2664581.6716554051.654-59%25055260.273-89%39939002.042-93%39081212.376-93%
Usd Book Value Change Per Share--0.042-0.016+137%-0.157+477%-0.014+134%0.001+3330%
Usd Book Value Per Share--0.0270.049-45%0.251-89%0.396-93%0.388-93%
Usd Dividend Per Share---0.118-100%-0%0.024-100%0.022-100%
Usd Eps---0.091-0.077-16%-0.106+16%-0.089-2%-0.083-10%
Usd Free Cash Flow---7835888.281-83693309.129+968%-9158687.731+17%-21677729.212+177%-19707026.557+151%
Usd Free Cash Flow Per Share---0.078-0.099+26%-0.092+17%-0.087+10%-0.087+10%
Usd Free Cash Flow To Equity Per Share---0.078-0.057-28%-0.032-59%-0.012-85%-0.012-85%
Usd Market Cap44132174.226+56%19544248.586951014755.360-98%159663901.753-88%605770417.373-97%557721407.148-96%
Usd Price Per Share0.442+56%0.1960.863-77%1.598-88%4.331-95%4.008-95%
Usd Profit---9123719.468-10614366.582+16%-12468184.089+37%-7995093.789-12%-7382572.430-19%
Usd Revenue--708357.107601953.677+18%950137.671-25%456435.747+55%414941.588+71%
Usd Total Gains Per Share--0.0420.103-60%-0.157+477%0.010+327%0.023+83%
 EOD+6 -2MRQTTM+13 -21YOY+14 -185Y+12 -2210Y+12 -22

3.2. Fundamental Score

Let's check the fundamental score of Renalytix AI plc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.209
Price to Book Ratio (EOD)Between0-116.563
Net Profit Margin (MRQ)Greater than0-12.880
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.186
Current Ratio (MRQ)Greater than10.681
Debt to Asset Ratio (MRQ)Less than10.878
Debt to Equity Ratio (MRQ)Less than17.202
Return on Equity (MRQ)Greater than0.15-3.424
Return on Assets (MRQ)Greater than0.05-0.417
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Renalytix AI plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.903
Ma 20Greater thanMa 5037.150
Ma 50Greater thanMa 10027.060
Ma 100Greater thanMa 20023.537
OpenGreater thanClose35.000
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Debt  -919,201-775,568-1,694,769700,030-994,738730,831-263,907481,969218,062
Net Working Capital  975,023691,2411,666,264-815,396850,868-748,093102,776-453,543-350,767



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets21,874
Total Liabilities19,207
Total Stockholder Equity2,667
 As reported
Total Liabilities 19,207
Total Stockholder Equity+ 2,667
Total Assets = 21,874

Assets

Total Assets21,874
Total Current Assets9,467
Long-term Assets12,407
Total Current Assets
Cash And Cash Equivalents 5,619
Short-term Investments 1,220
Net Receivables 1,370
Inventory 512
Other Current Assets 57
Total Current Assets  (as reported)9,467
Total Current Assets  (calculated)8,778
+/- 689
Long-term Assets
Property Plant Equipment 683
Intangible Assets 11,563
Long-term Assets Other 161
Long-term Assets  (as reported)12,407
Long-term Assets  (calculated)12,407
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities13,897
Long-term Liabilities5,310
Total Stockholder Equity2,667
Total Current Liabilities
Short Long Term Debt 3,063
Accounts payable 2,816
Total Current Liabilities  (as reported)13,897
Total Current Liabilities  (calculated)5,879
+/- 8,018
Long-term Liabilities
Long term Debt 5,310
Capital Lease Obligations Min Short Term Debt118
Long-term Liabilities  (as reported)5,310
Long-term Liabilities  (calculated)5,428
+/- 118
Total Stockholder Equity
Total Stockholder Equity (as reported)2,667
Total Stockholder Equity (calculated)0
+/- 2,667
Other
Capital Stock318
Common Stock Shares Outstanding 99,930
Net Debt 2,754
Net Invested Capital 11,040
Net Working Capital -4,430
Property Plant and Equipment Gross 1,682



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
> Total Assets 
0
31,340
31,340
28,922
28,922
42,480
42,480
0
41,298
91,197
91,015
85,348
78,576
67,265
80,867
44,466
63,258
38,713
30,660
39,802
30,629
19,540
21,874
21,87419,54030,62939,80230,66038,71363,25844,46680,86767,26578,57685,34891,01591,19741,298042,48042,48028,92228,92231,34031,3400
   > Total Current Assets 
0
13,261
13,261
9,398
9,398
21,418
21,418
18,397
18,896
86,649
78,844
72,837
66,791
56,160
51,367
37,283
47,431
34,426
26,601
35,728
26,882
16,471
9,467
9,46716,47126,88235,72826,60134,42647,43137,28351,36756,16066,79172,83778,84486,64918,89618,39721,41821,4189,3989,39813,26113,2610
       Cash And Cash Equivalents 
0
13,095
13,095
9,288
9,288
20,792
20,792
0
13,293
82,253
74,532
70,076
65,128
54,326
39,928
32,361
41,333
31,040
23,816
33,027
24,682
13,891
5,619
5,61913,89124,68233,02723,81631,04041,33332,36139,92854,32665,12870,07674,53282,25313,293020,79220,7929,2889,28813,09513,0950
       Short-term Investments 
0
0
0
0
0
0
0
0
982
0
0
0
9,295
0
7,033
0
2,744
0
1,487
0
793,322
0
1,220
1,2200793,32201,48702,74407,03309,29500098200000000
       Net Receivables 
0
59
59
0
0
0
0
0
18
18
725
479
670
456
823
1,085
2,677
1,311
820
747
-6,184,296
1,014
1,370
1,3701,014-6,184,2967478201,3112,6771,08582345667047972518180000059590
       Other Current Assets 
0
0
0
49
49
76
76
0
4,277
4,378
4,312
2,761
1,663
1,834
3,670
1,834
-483
3,386
0
1,879
1,424
1,566
57
571,5661,4241,87903,386-4831,8343,6701,8341,6632,7614,3124,3784,277076764949000
   > Long-term Assets 
0
0
18,079
0
19,524
0
21,062
0
22,402
4,548
12,171
12,511
11,785
11,105
29,500
7,183
15,827
4,287
4,059
4,074
3,747
3,069
12,407
12,4073,0693,7474,0744,0594,28715,8277,18329,50011,10511,78512,51112,1714,54822,402021,062019,524018,07900
       Property Plant Equipment 
0
410
410
278
278
722
722
1,072
945
2,644
2,603
2,594
2,490
2,632
1,852
2,850
1,723
2,587
2,508
2,373
1,186
1,075
683
6831,0751,1862,3732,5082,5871,7232,8501,8522,6322,4902,5942,6032,6449451,0727227222782784104100
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23,242,034
0
0
0023,242,03400000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
1,937
1,821
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000001,8211,93700000000
       Intangible Assets 
0
17,236
17,236
18,287
18,287
18,755
18,755
0
17,118
0
0
0
18,021
0
16,648
0
14,020
0
12,991
0
20,366,652
974
11,563
11,56397420,366,652012,991014,020016,648018,02100017,118018,75518,75518,28718,28717,23617,2360
       Other Assets 
0
433
433
959
959
1,585
1,585
457
2,402
83
4,525
0
7,172
0
10,963
0
0
0
139
0
1,101
0
0
001,101013900010,96307,17204,525832,4024571,5851,5859599594334330
> Total Liabilities 
0
809
809
755
755
1,304
1,304
0
5,336
4,076
4,118
5,322
7,115
7,292
9,216
15,051
20,089
19,870
21,775
21,705
23,662
21,031
19,207
19,20721,03123,66221,70521,77519,87020,08915,0519,2167,2927,1155,3224,1184,0765,33601,3041,3047557558098090
   > Total Current Liabilities 
0
809
809
755
755
1,304
1,304
1,303
3,383
3,809
3,720
5,240
7,062
7,239
8,966
15,037
12,205
13,334
14,287
14,684
16,136
15,173
13,897
13,89715,17316,13614,68414,28713,33412,20515,0378,9667,2397,0625,2403,7203,8093,3831,3031,3041,3047557558098090
       Short-term Debt 
0
0
0
0
0
0
0
0
982
0
141
226
53
0
130
0
4,823
4,601
4,719
4,602
4,593
4,700
0
04,7004,5934,6024,7194,6014,8230130053226141098200000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
121
161
141
226
53
0
0
0
4,660
4,473
4,590
4,473
4,463
4,569
3,063
3,0634,5694,4634,4734,5904,4734,6600005322614116112100000000
       Accounts payable 
0
809
809
315
315
1,304
1,304
585
2,221
1,829
864
1,066
1,764
1,659
2,387
3,063
7,281
4,262
4,148
3,199
2,936
3,368
2,816
2,8163,3682,9363,1994,1484,2627,2813,0632,3871,6591,7641,0668641,8292,2215851,3041,3043153158098090
       Other Current Liabilities 
0
0
0
0
0
0
0
49
180
1,980
2,715
3,948
5,298
5,580
5,495
11,974
101
300
31
9
10
7,105
0
07,1051093130010111,9745,4955,5805,2983,9482,7151,980180490000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
1,953
267
398
82
53
53
250
14
7,884
6,536
7,488
7,021
7,526
5,858
5,310
5,3105,8587,5267,0217,4886,5367,884142505353823982671,95300000000
       Other Liabilities 
0
0
0
0
0
0
0
0
1,544
173
232
53
53
53
0
14
0
0
0
0
0
0
0
00000001405353532321731,54400000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
457
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000004570000000
> Total Stockholder Equity
0
30,531
30,531
28,167
28,167
41,176
41,176
0
35,962
89,194
86,897
80,026
71,461
59,973
71,651
29,415
43,169
18,843
8,885
18,097
6,967
-1,491
2,667
2,667-1,4916,96718,0978,88518,84343,16929,41571,65159,97371,46180,02686,89789,19435,962041,17641,17628,16728,16730,53130,5310
   Common Stock
0
171
171
175
175
192
192
179
192
219
219
219
220
220
233
220
241
229
229
286
286
290
0
02902862862292292412202332202202192192191921791921921751751711710
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 00000000000-223-143-135-700-580-310-1500
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
76,457
0
0
0
0
0
0
0
0
0
0
000000000076,457000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
-10
-10
-63
-63
590
590
-1,165
988
149,048
155,667
157,652
158,683
157,301
90,632
156,760
95,889
163,285
163,771
185,032
185,006
186,698
0
0186,698185,006185,032163,771163,28595,889156,76090,632157,301158,683157,652155,667149,048988-1,165590590-63-63-10-100



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-09-30)

Gross Profit (+$)
totalRevenue2,893
Cost of Revenue-2,489
Gross Profit404404
 
Operating Income (+$)
Gross Profit404
Operating Expense-42,281
Operating Income-39,388-41,877
 
Operating Expense (+$)
Research Development13,328
Selling General Administrative26,471
Selling And Marketing Expenses-
Operating Expense42,28139,799
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income-39,388
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-43,805-39,388
EBIT - interestExpense = 0
-43,808
-43,808
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--43,805
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-43,805
Tax Provision-3
Net Income From Continuing Ops-43,808-43,808
Net Income-43,808
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Technical Analysis of Renalytix
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Renalytix. The general trend of Renalytix is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Renalytix's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Renalytix AI plc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 37.00 < 53.00 < 53.00.

The bearish price targets are: 25.00 > 24.00 > 20.88.

Tweet this
Renalytix AI plc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Renalytix AI plc. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Renalytix AI plc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Renalytix AI plc. The current macd is 1.46929032.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Renalytix price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Renalytix. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Renalytix price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Renalytix AI plc Daily Moving Average Convergence/Divergence (MACD) ChartRenalytix AI plc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Renalytix AI plc. The current adx is 38.16.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Renalytix shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Renalytix AI plc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Renalytix AI plc. The current sar is 61.63.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Renalytix AI plc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Renalytix AI plc. The current rsi is 52.90. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
Renalytix AI plc Daily Relative Strength Index (RSI) ChartRenalytix AI plc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Renalytix AI plc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Renalytix price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Renalytix AI plc Daily Stochastic Oscillator ChartRenalytix AI plc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Renalytix AI plc. The current cci is -36.79035953.

Renalytix AI plc Daily Commodity Channel Index (CCI) ChartRenalytix AI plc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Renalytix AI plc. The current cmo is 2.88456112.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Renalytix AI plc Daily Chande Momentum Oscillator (CMO) ChartRenalytix AI plc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Renalytix AI plc. The current willr is -46.7742794.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Renalytix is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Renalytix AI plc Daily Williams %R ChartRenalytix AI plc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Renalytix AI plc.

Renalytix AI plc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Renalytix AI plc. The current atr is 4.86638673.

Renalytix AI plc Daily Average True Range (ATR) ChartRenalytix AI plc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Renalytix AI plc. The current obv is 4,183,757.

Renalytix AI plc Daily On-Balance Volume (OBV) ChartRenalytix AI plc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Renalytix AI plc. The current mfi is 23.07.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Renalytix AI plc Daily Money Flow Index (MFI) ChartRenalytix AI plc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Renalytix AI plc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-16STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Renalytix AI plc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Renalytix AI plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.903
Ma 20Greater thanMa 5037.150
Ma 50Greater thanMa 10027.060
Ma 100Greater thanMa 20023.537
OpenGreater thanClose35.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Renalytix with someone you think should read this too:
  • Are you bullish or bearish on Renalytix? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Renalytix? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Renalytix AI plc

I send you an email if I find something interesting about Renalytix AI plc.


Comments

How you think about this?

Leave a comment

Stay informed about Renalytix AI plc.

Receive notifications about Renalytix AI plc in your mailbox!